NEW YORK (GenomeWeb) – In an investor note released this week, investment bank Piper Jaffray projected solid growth in 2015 for Fluidigm's CyTOF mass spectrometry platform.

The projection is based primarily on what Piper Jaffray sees as growing academic acceptance of the platform, based on a significant increase in publications using the instrument. The firm noted as well that it believes placing additional instruments with existing customers represents a significant opportunity for Fluidigm.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.